288 related articles for article (PubMed ID: 29682097)
1. Growth Differentiation Factor-15 as a Predictor of Idiopathic Membranous Nephropathy Progression: A Retrospective Study.
Ham YR; Song CH; Bae HJ; Jeong JY; Yeo MK; Choi DE; Na KR; Lee KW
Dis Markers; 2018; 2018():1463940. PubMed ID: 29682097
[TBL] [Abstract][Full Text] [Related]
2. Growth differentiation factor 15 as a predictor of adverse renal outcomes in patients with immunoglobulin A nephropathy.
Na KR; Kim YH; Chung HK; Yeo MK; Ham YR; Jeong JY; Kim KS; Lee KW; Choi DE
Intern Med J; 2017 Dec; 47(12):1393-1399. PubMed ID: 28869715
[TBL] [Abstract][Full Text] [Related]
3. Serum complement factor B is associated with disease activity and progression of idiopathic membranous nephropathy concomitant with IgA nephropathy.
Ji FP; Wen L; Zhang YP; Liu EP; Wen JG
Int Urol Nephrol; 2022 Jun; 54(6):1287-1294. PubMed ID: 34585312
[TBL] [Abstract][Full Text] [Related]
4. GDF-15 and sST-2 act as biomarkers of disease severity but not independent predictors in idiopathic membranous nephropathy.
Wu L; Luo L; Zhou L; Li N; Qin X
Int Immunopharmacol; 2022 Oct; 111():109150. PubMed ID: 36027852
[TBL] [Abstract][Full Text] [Related]
5. Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy.
Bazzi C; Usui T; Rizza V; Casellato D; Gallieni M; Nangaku M
Nephrology (Carlton); 2018 Feb; 23(2):175-182. PubMed ID: 27764902
[TBL] [Abstract][Full Text] [Related]
6. Comparison of prognostic, clinical, and renal histopathological characteristics of overlapping idiopathic membranous nephropathy and IgA nephropathy versus idiopathic membranous nephropathy.
Chen X; Chen Y; Shi K; Lv Y; Tong H; Zhao G; Chen C; Chen B; Li D; Lu Z
Sci Rep; 2017 Sep; 7(1):11468. PubMed ID: 28904360
[TBL] [Abstract][Full Text] [Related]
7. Serum uric acid is an independent predictor of renal outcomes in patients with idiopathic membranous nephropathy.
Zhang J; Pan M; Zhang J; You X; Li D; Lin F; Lu G
Int Urol Nephrol; 2019 Oct; 51(10):1797-1804. PubMed ID: 31463703
[TBL] [Abstract][Full Text] [Related]
8. Focal segmental glomerulosclerosis, excluding atypical lesion, is a predictor of renal outcome in patients with membranous nephropathy: a retrospective analysis of 716 cases.
He HG; Wu CQ; Ye K; Zeng C; Huang YY; Luo SW; Yin W; Ye QR; Peng XM
BMC Nephrol; 2019 Aug; 20(1):328. PubMed ID: 31438882
[TBL] [Abstract][Full Text] [Related]
9. Renal outcomes of idiopathic and atypical membranous nephropathy in adult Chinese patients: a single center retrospective cohort study.
Jiang Z; Cai M; Dong B; Yan Y; Wang Y; Li X; Shao C; Zuo L
BMC Nephrol; 2021 Apr; 22(1):148. PubMed ID: 33888083
[TBL] [Abstract][Full Text] [Related]
10. Circulating TNF receptors are significant prognostic biomarkers for idiopathic membranous nephropathy.
Lee SM; Yang S; Cha RH; Kim M; An JN; Paik JH; Kim DK; Kang SW; Lim CS; Kim YS; Lee JP
PLoS One; 2014; 9(8):e104354. PubMed ID: 25098821
[TBL] [Abstract][Full Text] [Related]
11. Serum anti-PLA2R antibody as a diagnostic biomarker of idiopathic membranous nephropathy: The optimal cut-off value for Chinese patients.
Liu Y; Li X; Ma C; Wang P; Liu J; Su H; Zhuo H; Kong X; Xu D; Xu D
Clin Chim Acta; 2018 Jan; 476():9-14. PubMed ID: 29126817
[TBL] [Abstract][Full Text] [Related]
12. The Association Between Serum Complement 4 and Kidney Disease Progression in Idiopathic Membranous Nephropathy: A Multicenter Retrospective Cohort Study.
Liu J; Zha Y; Zhang P; He P; He L
Front Immunol; 2022; 13():896654. PubMed ID: 35707542
[TBL] [Abstract][Full Text] [Related]
13. Association between Plasma Levels of Growth Differentiation Factor-15 and Renal Function in the Elderly: Korean Frailty and Aging Cohort Study.
Kim JS; Kim S; Won CW; Jeong KH
Kidney Blood Press Res; 2019; 44(3):405-414. PubMed ID: 31163432
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcome.
Chen A; Frank R; Vento S; Crosby V; Chandra M; Gauthier B; Valderrama E; Trachtman H
BMC Nephrol; 2007 Aug; 8():11. PubMed ID: 17683621
[TBL] [Abstract][Full Text] [Related]
15. New risk score for predicting progression of membranous nephropathy.
Xiaofan H; Jing X; Chenni G; Yifan W; Xialian Y; Li L; Hong R; Wen Z; Weiming W; Xiaoxia P; Jingyuan X; Nan C
J Transl Med; 2019 Feb; 17(1):41. PubMed ID: 30736804
[TBL] [Abstract][Full Text] [Related]
16. Detection and clinical significance of glomerular M-type phospholipase A
Liu H; Luo W; Gong S; Ding X
Intern Med J; 2016 Nov; 46(11):1318-1322. PubMed ID: 27554390
[TBL] [Abstract][Full Text] [Related]
17. Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy.
Kanigicherla D; Gummadova J; McKenzie EA; Roberts SA; Harris S; Nikam M; Poulton K; McWilliam L; Short CD; Venning M; Brenchley PE
Kidney Int; 2013 May; 83(5):940-8. PubMed ID: 23364522
[TBL] [Abstract][Full Text] [Related]
18. Application of miR-193a/WT1/PODXL axis to estimate risk and prognosis of idiopathic membranous nephropathy.
Zhang W; Ren Y; Li J
Ren Fail; 2019 Nov; 41(1):704-717. PubMed ID: 31352863
[No Abstract] [Full Text] [Related]
19. Baseline proteinuria level is associated with prognosis in idiopathic membranous nephropathy.
Chen X; Chen Y; Ding X; Zhou Y; Lv Y; Li D; Chen B; Chen T; Chen C
Ren Fail; 2019 Nov; 41(1):363-369. PubMed ID: 31057017
[TBL] [Abstract][Full Text] [Related]
20. [Value of plasma growth differentiation factor-15 in diagnosis and evaluation of type 2 diabetic nephropathy].
Li H; Gao F; Xue Y; Qian Y
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Mar; 34(3):387-90. PubMed ID: 24670455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
